Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Synthesis, characterization and biological application of 5-quinoline 1,3,5-trisubstituted pyrazole based platinum(II) complexes

Miral V. Lunagariya a, Khyati P. Thakor a, Reena R. Varma a, Bhargav N. Waghela b, Chandramani Pathak b and Mohan N. Patel *a
aDepartment of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India. E-mail: jeenen@gmail.com; Tel: +912692 226856 218
bDepartment of Cell Biology, School of Biological Sciences and Biotechnology, Indian Institute of Advanced Research, Koba Institutional Area, Gandhinagar-382007, Gujarat, India. Tel: +91 79 30514245

Received 25th January 2018 , Accepted 25th January 2018

First published on 2nd February 2018


Correction for ‘Synthesis, characterization and biological application of 5-quinoline 1,3,5-trisubstituted pyrazole based platinum(II) complexes’ by Miral V. Lunagariya et al., MedChemComm, 2018, DOI: 10.1039/c7md00472a.


The authors regret that ligands L1–L5 are not named correctly in the manuscript. The names are missing ‘4,5-dihydro’ as displayed in the experimental section. The correct names are as follows: 2-chloro-3-(3-(5-chlorothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)quinoline (L1), 2-chloro-3-(3-(4-methylthiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)quinoline (L2), 3-(3-(5-bromothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-2-chloroquinoline (L3), 3-(3-(3-bromothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-2-chloroquinoline (L4) and 2-chloro-3-(1-phenyl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-5-yl)quinoline (L5).

Scheme 1, with corrected name for L1–L5, is shown below.


image file: c8md90005a-s1.tif
Scheme 1

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2018